Indications |
Oral Androgen deficiency, Infertility due to hypogonadism Adult: Initially, 75-100 mg daily in divided doses. Maintenance: 50-75 mg daily in divided doses. |
Contraindications |
Prostatic or breast carcinoma. Previous or existing hepatic tumours. Pregnancy and lactation. |
Warnings / Precautions |
Regularly examine the prostate and breast during treatment. CV disorders, renal or hepatic impairment, epilepsy, migraine, DM or other conditions that may be exacerbated by the possible fluid retention or oedema. Skeletal metastases (risk of hypercalcaemia). Children. Monitor skeletal maturation during therapy. |
Adverse Reactions |
Frequent or persistent erections. Potentially Fatal: Malignant liver tumours. |
Drug Interactions |
Enhances effects of ciclosporin, antidiabetics, levothyroxine, anticoagulants e.g. warfarin. Resistance to the effects of neuromuscular blockers may occur. See Below for More mesterolone Drug Interactions |
Lab Interactions |
May Interfere with glucose tolerance and thyroid function tests. |
Mechanism of Actions |
Mesterolone is an androgen with less inhibitory effects on intrinsic testicular function compared to testosterone. Absorption: Rapidly and almost completely absorbed (oral); peak serum levels in about 1.6 hr. Distribution: Protein-binding: About 40% to albumin and 58% to sex-hormone binding globulin. Metabolism: Rapidly metabolised; absolute bioavailability: 3% of the oral dose. Not metabolised to oestrogenic compounds. Excretion: Via urine (approx 77% of the metabolites); via faeces (approx 13%); 12-13 hr (terminal half-life). |
Administration |
May be taken with or without food. |
ATC Classification |
G03BB01 - mesterolone ; Belongs to the class of 5-androstanon (3) derivative androgens used in androgenic hormone preparations. |
Available As |
|
Mesterolone
Post Review about Mesterolone Click here to cancel reply.
Mesterolone Containing Brands
Mesterolone is used in following diseases
Drug - Drug Interactions of Mesterolone
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.